Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Liabilities and Shareholders Equity (2023 - 2025)

Metagenomi (MGX) has disclosed Liabilities and Shareholders Equity for 3 consecutive years, with $221.1 million as the latest value for Q4 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 31.88% to $221.1 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.0 billion, a 29.99% decrease, with the full-year FY2025 number at $221.1 million, down 31.88% from a year prior.
  • Liabilities and Shareholders Equity was $221.1 million for Q4 2025 at Metagenomi, down from $247.9 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $415.4 million in Q1 2024 to a low of $221.1 million in Q4 2025.
  • A 3-year average of $320.9 million and a median of $324.6 million in 2024 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: decreased 11.03% in 2024, then plummeted 31.88% in 2025.
  • Metagenomi's Liabilities and Shareholders Equity stood at $364.8 million in 2023, then decreased by 11.03% to $324.6 million in 2024, then tumbled by 31.88% to $221.1 million in 2025.
  • Per Business Quant, the three most recent readings for MGX's Liabilities and Shareholders Equity are $221.1 million (Q4 2025), $247.9 million (Q3 2025), and $272.3 million (Q2 2025).